What We Can Really Do with Bioresponsive MRI Contrast Agents
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Bioresponsive MRI contrast agents hold great promise for monitoring major physiological and pathological processes in a non‐invasive manner. They are capable of altering the acquired MRI signal as a consequence of changes in their microenvironment, thus allowing real‐time functional reporting in living organisms. Importantly, chemistry offers diverse solutions for the design of agents which respond to a great number of specific targets. However, the path to the successful utilization of these biomarkers in the desired functional MRI studies involves careful consideration of multiple scientific, technical, and practical issues across various research disciplines. This Minireview highlights the critical steps for planning and executing such multidisciplinary projects with an aim to substantially improve our knowledge of essential biological processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
What we can do and what we cannot do with fMRI
Logothetis, N. K. (2008) · Nature · doi:10.1038/nature06976 · Cited by 3,612
Chemical exchange saturation transfer (CEST): what is in a name and what isn't?
van Zijl, P. C. M., & Yadav, N. N. (2011) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22761 · Cited by 1,155
Tissue Engineering and Regenerative Medicine: History, Progress, and Challenges
Berthiaume, F., Maguire, T. J., & Yarmush, M. L. (2011) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-061010-114257 · Cited by 734
Cited by
Engineering of inorganic nanoparticles as magnetic resonance imaging contrast agents
Ni, D., Bu, W., Ehlerding, E. B., Cai, W., & Shi, J. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00316a · Cited by 484
Ren, Z., Sun, S., Sun, R., Cui, G., Hong, L., Rao, B., Li, A., Yu, Z., Kan, Q., & Mao, Z. (2020) · Advanced Materials · doi:10.1002/adma.201906024 · Cited by 446
Molecular magnetism, quo vadis? A historical perspective from a coordination chemist viewpoint☆
Ferrando-Soria, J., Vallejo, J., Castellano, M., Martínez-Lillo, J., Pardo, E., Cano, J., Castro, I., Lloret, F., Ruiz-García, R., & Julve, M. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.03.004 · Cited by 348
Molecular Magnetic Resonance Imaging with Gd(III)-Based Contrast Agents: Challenges and Key Advances
Li, H., & Meade, T. J. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b09149 · Cited by 288
Surface Enhanced Spatially Offset Raman Spectroscopy Detection of Neurochemicals Through the Skull
Moody, A. S., Baghernejad, P. C., Webb, K. R., & Sharma, B. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b00985 · Cited by 56
Yue, N.-N., Xu, H.-M., Xu, J., Zhu, M.-Z., Zhang, Y., Tian, C.-M., Nie, Y.-Q., Yao, J., Liang, Y.-J., Li, D.-F., et al. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s413141 · Cited by 46
“MRI MRI has extensive clinical applicability in diagnosing GI diseases due to its non-invasive and non-ionizing radiation, excellent spatiotemporal resolution, accurate soft tissue contrast, and deep-tissue penetration.(226) Protons within the body are excited by RF pulse energy in a magnetic field and emit radio wave…”
BackgroundSurface modifications of nanoparticles and their suitability for studying gastrointestinal diseases
Obasi, C. C., & Banigo, A. T. (2026) · Nano-Bio-Medicine for Gastrointestinal Diseases · doi:10.1016/b978-0-443-34039-0.00010-x · Cited by 2
Metadata
- Authors
- Angelovski, G.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2016-04-26
- Volume
- 55
- Issue
- 25
- Pages
- 7038-7046
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2344679303
- Cited by
- 114
- References
- 4
- FWCI
- 5.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.